Drug Shows Promise for Progressive Multiple Sclerosis
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
Medical Students Share Research Projects at AOSC Poster Session
Second-year medical students showcased ongoing results from their Area of Scholarly Concentration projects at a recent poster session.
Brain Tumor SPORE Drives Rapid Translation
Northwestern Medicine investigators are leading a Specialized Program of Research Excellence (SPORE) in brain cancer with a special emphasis on glioblastoma.